Volver a los detalles del artÃculo
Renal Outcomes of GLP-1 Receptor Agonists (Semaglutide and Tirzepatide) in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Multicenter Latin American Study
Descargar
Descargar PDF